The Scientific World Journal / 2012 / Article / Tab 2

Research Article

Potential Canonical Wnt Pathway Activation in High-Grade Astrocytomas

Table 2

Clinicopathological characteristics of patients included in TMA analysis.

Histological diagnosisPatients
  𝑛 = 2 8 3 (%) 

GlioblastomaWHO IV221 (78.1)
Anaplastic astrocytomaWHO III17 (6.0) 
Diffuse astrocytomaWHO II45 (15.9) 

Age mean ( 𝑦 ) Β± SD 

GlioblastomaWHO IV53.8 Β± 12.8 
Anaplastic astrocytomaWHO III36.1 Β± 14.2 
Diffuse astrocytomaWHO II33.6 Β± 18.7 

GenderM : F 

GlioblastomaWHO IV133 : 88 
Anaplastic astrocytomaWHO III11 : 6 
Diffuse astrocytomaWHO II30 : 15 

Extent of resectionTotalSubtotal/biopsy
   𝑛 = (%) 𝑛 = (%)

GlioblastomaWHO IV151 (68.3)70 (31.7)
Anaplastic astrocytomaWHO III11 (64.7)6 (35.3)
Diffuse astrocytomaWHO II33 (73.3)12 (26.7)

Adjuvant treatment†RadiotherapyChemotherapy
   𝑛 = (%) 𝑛 = (%)

GlioblastomaWHO IV186 (84.2)87 (39.4)
Anaplastic astrocytomaWHO III16 (94.1)1 (5.9)
Diffuse astrocytomaWHO II14 (31.1)3 (6.7)

†Therapy at primary tumour diagnosis.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.